share_log

Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $38

Moomoo 24/7 ·  Apr 3 14:35

Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target from $31 to $38.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment